Risk-adaptive paradigm for focal versus whole-gland salvage treatment for radio-recurrent prostate cancer

Risk-adaptive paradigm for focal versus whole-gland salvage treatment for radio-recurrent prostate cancer

Bibliographic Details
Main Authors:	Martin T. King, David D. Yang, Anthony V. D’Amico, Ivan Buzurovic, Thomas C. Harris, Christian V. Guthier, Graeme S. Steele, Martin N. Kathrins, Atish D. Choudhury
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-09-01
Series:	Frontiers in Oncology
Subjects:	radiorecurrent prostate cancer SBRT brachytherapy MRI PSMA
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.998390/full

Similar Items

CyberKnife boost for patients with cervical cancer unable to undergo brachytherapy
by: Jonathan Andrew Haas, et al.
Published: (2012-03-01)

The use of Lutetium-177 PSMA radioligand therapy with high dose rate brachytherapy for locally recurrent prostate cancer after previous definitive radiation therapy: a randomized, single-institution, phase I/II study (ROADSTER).
by: Lucas C. Mendez, et al.
Published: (2023-04-01)

Dose escalation with stereotactic body radiotherapy for cervical cancer treatment
by: Menekse Turna, et al.
Published: (2024-10-01)

Enhancing Androgen Deprivation Therapy (ADT) integration in prostate cancer: Insights for Stereotactic Body Radiotherapy (SBRT) and brachytherapy modalities
by: A. Gomez-Iturriaga, et al.
Published: (2024-03-01)

Imaging Biomarkers in Prostate Stereotactic Body Radiotherapy: A Review and Clinical Trial Protocol
by: Wei Liu, et al.
Published: (2022-04-01)

Focal salvage treatment for radiorecurrent prostate cancer: A magnetic resonance-guided stereotactic body radiotherapy versus high-dose-rate brachytherapy planning study
by: Thomas Willigenburg, et al.
Published: (2020-07-01)

Salvage Magnetic Resonance Imaging–guided Transurethral Ultrasound Ablation for Localized Radiorecurrent Prostate Cancer
by: Mikael Anttinen, et al.
Published: (2025-01-01)

Re‐salvage focal low‐dose rate brachytherapy for local recurrence of prostate cancer after salvage focal low‐dose rate brachytherapy
by: Takahiro Nakamoto, et al.
Published: (2024-01-01)

Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)
by: Gregor Habl, et al.
Published: (2017-05-01)

Radiotherapy as a metastasis directed therapy for liver oligometastases - comparative analysis between CT-guided interstitial HDR brachytherapy and two SBRT modalities performed on double-layer and single layer LINACs
by: Mateusz Bilski, et al.
Published: (2024-11-01)

Feasibility and clinical implementation of MRI-guided surface brachytherapy
by: Michael J. Lavelle, et al.
Published: (2024-02-01)

Evaluating [<sup>68</sup>Ga]-Ga PSMA PET/CT for Detecting Prostate Cancer Recurrence Post-High-Intensity Focused Ultrasound and Brachytherapy: A Single-Center Retrospective Study
by: Andrea Di Giorgio, et al.
Published: (2024-12-01)

Efficacy and toxicity outcomes for patients treated with focal salvage high dose rate brachytherapy for locally recurrent prostate cancer
by: Finbar Slevin, et al.
Published: (2020-07-01)

Image-Guided Stereotactic Body Radiotherapy on Detectable Prostate Bed Recurrence after Prostatectomy in RT-Naïve Patients
by: Riccardo Santamaria, et al.
Published: (2024-07-01)

Estimation of Annual Secondary Lung Cancer Deaths Using Various Adjuvant Breast Radiotherapy Techniques for Early-Stage Cancers
by: Jean-Philippe Pignol, et al.
Published: (2021-08-01)

Are liver contour and bone fusion comparable to fiducials for IGRT in liver SBRT?
by: C. de la Pinta, et al.
Published: (2023-09-01)

Focal Prostate Stereotactic Body Radiation Therapy With Correlative Pathological and Radiographic-Based Treatment Planning
by: Elisha Fredman, et al.
Published: (2021-09-01)

The SAFE Pilot Trial—SAlvage Focal Irreversible Electroporation—For Recurrent Localized Prostate Cancer: Rationale and Study Protocol
by: Giancarlo Marra, et al.
Published: (2022-06-01)

Long Term Results of Elective Nodal Salvage Radiotherapy in Oligometastatic Prostate Cancer : A Mono-Institutional Series
by: Riccardo Vigna-Taglianti, et al.
Published: (2022-10-01)

Vaginal toxicity after high-dose-rate endovaginal brachytherapy: 20 years of results
by: Durim Delishaj, et al.
Published: (2018-11-01)

Physical and Dosimetric Aspects of the Iridium-Knife
by: Yiannis Roussakis, et al.
Published: (2021-11-01)

TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II
by: Shankar Siva, et al.
Published: (2018-10-01)

Salvage focal brachytherapy in castration‐resistant prostate cancer with neuroendocrine differentiation after radiation therapy
by: Takahiro Komori, et al.
Published: (2022-07-01)

Whole-gland salvage treatment for recurrent prostate cancer after initial definitive radiotherapy: A case series of 125I brachytherapy and robot-assisted radical prostatectomy
by: Shinya Sutani, et al.
Published: (2019-06-01)

Tubarial salivary glands on PSMA ligands based PET imaging and post 177Lu PSMA therapy scan: reiterating its importance
by: Srinivas Kumar, et al.
Published: (2024-01-01)

Biochemical failure-free survival of 18F-rhPSMA-7 and 18F-flotufolastat PET-guided salvage radiotherapy for patients with recurrent prostate cancer
by: Marco M. E. Vogel, et al.
Published: (2025-01-01)

Nonmetastatic castration‐resistant prostate cancer treated with salvage focal brachytherapy after external beam radiotherapy
by: Soichiro Yoshida, et al.
Published: (2021-07-01)

Second breast-conserving therapy with interstitial brachytherapy (APBI) as a salvage treatment in ipsilateral breast tumor recurrence: a retrospective study of 40 patients
by: Salvatore Cozzi, et al.
Published: (2019-04-01)

A review of whole gland prostate brachytherapy with focal dose escalation to intra-prostatic lesions: Clinical efficacy and technical aspects
by: Joel Poder, et al.
Published: (2024-10-01)

1-, 3-, and 5-year survival among early-stage lung cancer patients treated with lobectomy vs SBRT
by: Albano D, et al.
Published: (2018-08-01)

Toxicity profile and Patient-Reported outcomes following salvage Stereotactic Ablative Radiation Therapy to the prostate Bed: The POPART multicentric prospective study
by: Federica Ferrario, et al.
Published: (2024-01-01)

Stereotactic Body Radiotherapy: Hitting Harder, Faster, and Smarter in High-Risk Prostate Cancer
by: Rohann J. M. Correa, et al.
Published: (2022-07-01)

Focal salvage high-dose-rate brachytherapy with implantable rectum spacer for locally recurrent prostate cancer after initial low-dose-rate with grade 3 rectal toxicity
by: Thirza Opbroek, et al.
Published: (2023-03-01)

Focal therapy for prostate cancer: the technical challenges
by: Annette Haworth, et al.
Published: (2017-08-01)

Focal therapy of prostate cancer: Assessment with prostate-specific membrane antigen (PSMA) imaging
by: Mark Topoozian, et al.
Published: (2023-09-01)

Target definition in salvage radiotherapy for recurrent prostate cancer: the role of advanced molecular imaging
by: Gaël eAmzalag, et al.
Published: (2016-03-01)

Clinical outcomes following high-dose-rate surface applicator brachytherapy for angiosarcoma of scalp and face
by: Devarati Mitra, et al.
Published: (2021-04-01)

LINAC-based SBRT in treating early-stage NSCLC patients—single institution experience and survival data analysis
by: Árpád Kovács, et al.
Published: (2024-02-01)

Robotic Stereotactic Body Radiotherapy for Spine Metastasis Pain Relief
by: Daniel Rivas, et al.
Published: (2024-02-01)

Intensity modulated radiation therapy with stereotactic body radiation therapy boost for unfavorable prostate cancer: five-year outcomes
by: Michael Carrasquilla, et al.
Published: (2023-11-01)